DA-5217

· Dong-A ST Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DA-5217, covering 2025-08-22 to 2025-08-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Pharmacokinetics and Safety of Diluted vs. Undiluted Intravenous DA-5217 in Healthy Adult Subjects [Phase 1]

See pricing